API Holdings Directly Absorbs 51.02% Stake in Thyrocare Following Docon Amalgamation
Thyrocare Technologies Ltd 路 Others (Uncategorized) 路 04 Sept 2026, 10:00 pm
API Holdings Directly Absorbs 51.02% Stake in Thyrocare Following Docon Amalgamation API Holdings has completed its amalgamation with Docon Technologies following NCLT Mumbai approval on 31st Aug'26 and RoC filing on 3rd Sep'26. Effective 3rd Sep'26, Docon stands merged into API Holdings, resulting in the direct transmission and vesting of Docon's entire holding of 8,12,00,000 equity shares (51.02% stake) in Thyrocare Technologies to API Holdings. The transaction was executed under SEBI Takeover Regulation 10(1)(d)(iii) exemptions, leaving the overall promoter and promoter group aggregate shareholding in Thyrocare unchanged.
Original exchange filing (PDF)
More announcements from Thyrocare Technologies Ltd
- Please find the enclosed announcement. 路 06 Nov 2026
- Please find the enclosed intimation. 路 06 Nov 2026
- Please find attached the Earnings Call Transcript held on October 29, 2026 路 02 Nov 2026
- Please find attached Intimation regarding the Execution of Share Purchase Agreement 路 30 Oct 2026
- Audio Recording of Earnings Conference Call for the Quarter and Half Year Ended September 30, 2026 路 30 Oct 2026
- Please find attached the Investor Presentation on the unaudited financial results (standalone and consolidated) for the quarter and half year ended on September 30, 2026 路 29 Oct 2026
- Please find attached the Press Release on the unaudited financial results (Standalone and Consolidated) for the quarter and half year ended on September 30, 2026 路 29 Oct 2026
- Please find enclosed the unaudited standalone and consolidated financial results of the Company for the quarter and half year ended on September 30, 2026 路 29 Oct 2026
